https://www.selleckchem.com/pr....oducts/Gefitinib.htm
1% +54.3%, P=0.02; +17.6% . +56.1%, P=0.006; and +29.8% +63.9%, P0.001) differed between PVE and LVD group. LVD (P=0.009), age (P=0.027) and baseline FLR-V (P=0.001) independently predicted FLR-V variations, whereas only LVD (P=0.01) predicted FLR-F changes. After missing data handling, LVD remained an independent predictor of FLR-V and FLR-F variations. LVD is safe and provides greater FLR-V and FLR-F increase than PVE. These results are now evaluated in the HYPERLIV-01 multicenter randomized trial. LVD is safe and provides great
Like
Comment
Share
